Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock

Wellgistics Health (NASDAQ:WGRX) announced that holders of 1,333,930 common shares, representing a majority of its outstanding common stock, have entered a minimum 90-day lock-up agreement restricting sales into the market.

Rhea-AI Summary

Wellgistics Health (NASDAQ:WGRX) announced that holders of 1,333,930 common shares, representing a majority of its outstanding common stock, have entered a minimum 90-day lock-up agreement restricting sales into the market.

According to Wellgistics, this, together with recently restructured convertible liabilities and new funding, reflects shareholder confidence in its vertically integrated growth plan.

Positive

• 1,333,930 common shares, a majority stake, placed under a 90-day lock-up
• Convertible liabilities restructured alongside new funding raised, as referenced by management
• Lock-up and recent financing actions presented as shareholder confidence in the execution plan

Negative

• None.

Argus May 28 session

+17.72% close to close Open Argus

Details

News Market Reaction – WGRX

On May 28, the day this news came out, WGRX closed 17.72% above the previous close.

Data tracked by StockTitan Argus for the May 28 session.

Market Context

On May 28, the day this news came out, the stock closed 17.7% above the previous close. A strong pos...

Analysis

On May 28, the day this news came out, the stock closed 17.7% above the previous close. A strong positive reaction aligns with signs of tighter float and insider alignment, as holders of 1,333,930 shares agreed to a minimum 90-day lock-up. Past history shows material news sometimes drew sharp moves, both on strategic deals and capital-structure changes. Investors would still have needed to weigh the effective $200,000,000 S‑3 shelf and significant planned ownership shifts from prior filings when assessing the durability of any rally.

Key Figures

Locked-up shares: 1,333,930 shares Lock-up period: 90 days Shelf registration size: $200,000,000 +5 more

Locked-up shares

1,333,930 shares

Common shares subject to minimum 90-day lock-up

Lock-up period

90 days

Minimum duration during which locked shares cannot be sold

Shelf registration size

$200,000,000

Maximum aggregate securities under S-3 shelf

Combined asset value

$4.0 billion

Target value of contributed assets in multi-step transaction

New holder ownership

89.6%

Expected common stock ownership after preferred conversion

Existing holder ownership

10.4%

Expected post-transaction stake for current public stockholders

Note principal

$1.5 million

Principal of amended note purchase agreement

Increased cash funding

$1.2 million

Investor cash funding under amended note agreement

Historical Context

5 past events · Latest: May 26

5 events

1. May 26

   Reverse split completed

   24h Move

   -7.6%

   Completion of 1-for-50 reverse stock split to address Nasdaq bid-price.

2. May 21

   Shareholder letter

   24h Move

   -17.1%

   Corrected shareholder letter detailing vertically integrated blockchain-based strategy.

3. May 21

   Shareholder letter

   24h Move

   -17.1%

   Strategic update tied to binding term sheet integrating EinsteinRx with PharmacyChain.

4. May 20

   Reverse split announcement

   24h Move

   -17.1%

   Planned 1-for-50 reverse split to regain Nasdaq minimum bid compliance.

5. May 20

   Strategic transactions

   24h Move

   -25.6%

   Binding term sheet to form DelivMeds AI with assets valued near $4 billion.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

lock-up agreement, convertible liabilities

2 terms

lock-up agreement financial

"have entered into a lock-up agreement that precludes the sale of their shares"

A lock-up agreement is a contract that prevents company insiders and early investors from selling their shares for a fixed period after a stock sale, often after an initial public offering. It matters to investors because it temporarily limits the number of shares that can hit the market, which can keep the share price steadier; when the lock-up ends, a sudden increase in available shares can create extra volatility, revealing insiders’ confidence or lack thereof.

convertible liabilities financial

"combined with the recent restructuring of our convertible liabilities and the raising of new funding"

Liabilities that can be changed into a company's common shares under set terms, such as a loan, bond or preferred claim that a holder can swap for stock instead of cash repayment. They matter to investors because conversion can dilute existing ownership, alter debt levels and shift who has control or upside; think of it as a loan that can be turned into part-ownership, changing both risk and potential reward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement

TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that holders of a 1,333,930 common shares, representing a majority of the outstanding common shares of the Company, have entered into a lock-up agreement that precludes the sale of their shares into the market for at least 90 days.

"This lock-up agreement, when combined with the recent restructuring of our convertible liabilities and the raising of new funding, underscores the confidence our shareholders have in management to execute against our recently-disclosed vertically-integrated growth plan outlined in the Company's recent shareholder letter," said Wellgistics Health Interim Co-CEO Gerald Commissiong. "We believe we will achieve important milestones against our execution plan in the weeks and months ahead. We look forward to updating the market as we make progress in achieving such milestones."

About Wellgistics Health, Inc.

Wellgistics Health (NASDAQ:WGRX) is a Health IT leader integrating its proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects more than 6,500 pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility verification, onboarding, adherence support, prior authorization, and cash-pay fulfillment designed to improve patient access and transparency across the prescription ecosystem.

For more information, visit www.wellgisticshealth.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Company's recently disclosed growth plan, anticipated milestones, expected market updates, the expected benefits of the lock-up agreement, the Company's shareholder support, management's ability to execute its business strategy, the Company's technology platforms, strategic initiatives, liquidity position, capital resources and Nasdaq compliance.

Forward-looking statements are based on current expectations, estimates, projections and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, risks related to the Company's ability to execute its growth plan; achieve anticipated milestones; maintain shareholder, investor and market support; obtain, maintain or utilize additional financing; successfully integrate, commercialize and scale its business initiatives and technology platforms; maintain compliance with Nasdaq listing standards; and manage market, regulatory, operational and competitive risks affecting the healthcare, pharmacy, pharmaceutical distribution, artificial intelligence and technology sectors, as well as other risks described in the Company's filings with the Securities and Exchange Commission.

Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Wellgistics Media & Investor Contact
Media: media@wellgisticshealth.com
Investor Relations: IR@wellgisticshealth.com

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What lock-up agreement did Wellgistics Health (NASDAQ:WGRX) announce on May 28, 2026?

Wellgistics Health announced a lock-up agreement covering a majority of its common shares. According to Wellgistics, the agreement prevents participating shareholders from selling their shares into the market for at least 90 days, supporting stability while the company pursues its vertically integrated growth plan.

How many Wellgistics Health (WGRX) shares are subject to the new lock-up?

The lock-up agreement covers 1,333,930 common shares of Wellgistics Health. According to Wellgistics, these shares represent a majority of the company’s outstanding common stock, meaning most existing holders involved have agreed not to sell during the 90-day lock-up period.

How long will the Wellgistics Health (WGRX) lock-up agreement remain in effect?

The lock-up agreement will last for a minimum of 90 days. According to Wellgistics, during this period the participating shareholders are precluded from selling their common shares into the market, aligning with the company’s near-term execution milestones described in its recent shareholder communications.

What does the Wellgistics Health (WGRX) lock-up mean for shareholders?

The lock-up restricts sales of a majority of Wellgistics Health’s shares for at least 90 days. According to Wellgistics, combined with restructured convertible liabilities and new funding, this arrangement reflects shareholders’ confidence in management’s ability to execute its vertically integrated growth plan.

How is the Wellgistics Health (WGRX) lock-up linked to its growth and funding plans?

The lock-up is presented as part of a broader capital and growth strategy. According to Wellgistics, it complements recent restructuring of convertible liabilities and new funding, supporting execution of its vertically integrated growth plan and expected milestones in the coming weeks and months.